<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>CyborgsLife — Policy</title><description>Policy coverage from the CyborgsLife market watch.</description><link>https://cyborgslife.com/</link><item><title>The EU AI Act&apos;s transparency duties become applicable</title><link>https://cyborgslife.com/capsules/eu-ai-act-article-50-applicable-2026/</link><guid isPermaLink="true">https://cyborgslife.com/capsules/eu-ai-act-article-50-applicable-2026/</guid><description>From 2 August 2026, providers must disclose AI interaction and mark synthetic media, and deployers must tell people when emotion recognition or biometric categorisation is in use.</description><pubDate>Fri, 07 Aug 2026 00:00:00 GMT</pubDate><category>policy</category><category>ai</category><category>ethics</category></item><item><title>HuidaGene discloses a CRISPR trial death twelve months late</title><link>https://cyborgslife.com/capsules/huidagene-hg302-trial-death-2026/</link><guid isPermaLink="true">https://cyborgslife.com/capsules/huidagene-hg302-trial-death-2026/</guid><description>HuidaGene Therapeutics waited a year to disclose that a boy in the high-dose cohort of its Duchenne gene-editing trial died in August 2025.</description><pubDate>Fri, 07 Aug 2026 00:00:00 GMT</pubDate><category>biotech</category><category>ethics</category><category>policy</category></item><item><title>Intellia ties its worst liver signals to a single HLA allele</title><link>https://cyborgslife.com/capsules/intellia-nex-z-hla-liver-risk-2026/</link><guid isPermaLink="true">https://cyborgslife.com/capsules/intellia-nex-z-hla-liver-risk-2026/</guid><description>A genomic analysis of more than 600 samples found the highest liver enzyme elevations in Intellia in vivo CRISPR trials clustered in carriers of one HLA allele.</description><pubDate>Fri, 07 Aug 2026 00:00:00 GMT</pubDate><category>biotech</category><category>policy</category></item></channel></rss>